Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy

Pamela A Long,Jeanne L Theis,Yu-Huan Shih,Joseph J Maleszewski,Patrice C Abell Aleff,Jared M Evans,Xiaolei Xu,Timothy M Olson,Pamela A. Long,Jeanne L. Theis,Joseph J. Maleszewski,Patrice C. Abell Aleff,Jared M. Evans,Timothy M. Olson
DOI: https://doi.org/10.1093/hmg/ddx169
IF: 5.1214
2017-05-02
Human Molecular Genetics
Abstract:Non-ischemic dilated cardiomyopathy (DCM) has been recognized as a heritable disorder for over 25 years, yet clinical genetic testing is non-diagnostic in >50% of patients, underscoring the ongoing need for DCM gene discovery. Here, whole exome sequencing uncovered a novel molecular basis for idiopathic end-stage heart failure in two sisters who underwent cardiac transplantation at three years of age. Compound heterozygous recessive mutations in TAF1A, encoding an RNA polymerase I complex protein, were associated with marked fibrosis of explanted hearts and gene-specific nucleolar segregation defects in cardiomyocytes, indicative of impaired ribosomal RNA synthesis. Knockout of the homologous gene in zebrafish recapitulated a heart failure phenotype with pericardial edema, decreased ventricular systolic function, and embryonic mortality. These findings expand the clinical spectrum of ribosomopathies to include pediatric DCM.
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?